ID: MRFR/Pharma/5069-HCR | 100 Pages | Author: Rahul Gotadki | December 2023
The pharmaceutical robots market is expected to register a CAGR of 9.8% to reach USD 351 billion by 2022-2030, estimates Market Research Future (MRFR). Pharmaceutical robots are automated machines used in hospitals and pharmacies to deliver pharmaceuticals. They are often controlled by computer software and are designed to do duties such as pill counting, medicine mixing, and delivery to patients. Pharmaceutical manufacturing benefits from robotic systems include higher production flexibility, reduced production downtime, no personnel turnover, improved health and safety, better waste management, improved production output, and product quality, and cheaper operating costs.
The necessity for automation in manufacturing plants, as well as the high expenses of drug discovery, are driving the growth of the pharmaceutical robots market. With the increasing demand for new medicines and medications, the majority of pharmaceutical companies are focusing on increasing the production of automated equipment and robots to meet the rising demand for high speed and precision. Traditional robots, such as cartesian robots, SCARA robots, and articulated robots, will increase rapidly in tandem with collaborative robotics.
The rising demand for pharmaceutical robots can be traced back to two major factors: the high costs of drug research and the increasing need for automation in production facilities. Companies in the pharmaceutical industry are responding to the increased demand for new medicines and pharmaceuticals by investing heavily in the development of automated equipment and robots. Traditional robots will proliferate at the same time as collaborative robotics, and this includes cartesian robots, SCARA robots, and articulated robots.
Robotics for automating processes in clinical trials, drug development, and laboratories are in great demand due to the rising need for automation in manufacturing units and the high expenses of new drug research. The introduction of highly sophisticated robotic devices by leading corporations has also contributed to the market's meteoric rise. Automation and robots have become increasingly popular in the pharmaceutical business in response to escalating demands for precision, production, and shorter turnaround times. There are also several time-saving advantages to employing robots in the pharmaceutical industry. The need for rigorous drug inspection is growing around the globe, especially in the pharmaceutical industry.
March 2023: Stäubli Robotics plans to show how its robots may improve product safety and efficacy as well as assist firms grow production in March 2023. Stäubli has been increasing its range, providing new levels of adaptability, safety, and performance in response to the growing difficulties in the pharmaceutical and biotechnology industries brought on by tighter laws and increasing market expectations. Introduced in 2022, the Stericlean+ series of robots is made specifically for use in sterile environments like isolation wards. New FDA-compliant dynamic sealings and a coating on all surfaces contribute to its increased ease of cleaning.
Report Overview
This MRFR's market research report delivers a comprehensive analysis of key trends in the global pharmaceutical robots market. It includes a detailed discussion on the historical trends, current market status, growth opportunities and challenges backed by fact-based feedbacks. The primary types of pharmaceutical robots that are covered in the report are traditional and collaborative robots. For opportunity analysis, the application areas of pharmaceutical robots have been assessed in the report, which include picking and packaging, pharmaceutical drugs inspection and laboratory applications. The end-users discussed in the report are pharmaceutical companies and research laboratories. the sub-markets covered in the report are profiled under four major regions that include North America, Europe, Asia Pacific and the rest of the world.
Report Coverage
MRFR's report on the global pharmaceutical robots market covers historical market trends, current market dynamics, market valuation by segmentation and region, country-level breakdown for market segments, competitive landscape, key player's market share analysis and supply chain analysis.
Companies Covered
Research Methodology
MRFR leverages its industry expertise for the deliverance of qualitative and quantitative analysis of current market trends, growth opportunities, latest developments, challenges and consumer landscape. Data analytics through primary and secondary research processes is carried out for providing comprehensive market insights. Surveys and first-hand interviews are conducted for collection of primary data which is then verified by using secondary research process where paid databases, SEC filings, white papers, research publications and other credible sources available in public domain are utilized as references. The combination of data triangulation technique and top-down and bottom-up approaches ensures the deliverance of accurate market foresight by gauging the market dynamics.
Recent Development
Multiply Labs, a robotics business, has partnered with Thermo Fisher Scientific and Charles River Pharmaceuticals to automate cell treatment production. Multiply Labs is armed itself with two more pieces of industry-leading technology in order to automate manual elements of the cell therapy production process. The new kit arrives a little over a year after the robotics firm announced a consortium aiming at developing a robotic manufacturing system for mass-producing cell treatments.
Engel, a producer of injection molding machines and automation, has purchased a majority stake in TMA Automation, a Polish company. TMA provides automation solutions for in-mold labeling, palletizing, quality inspection, and more. Engel will be able to deliver highly integrated and completely automated injection molding production cells from a single supplier after acquiring TMA. While TMA will focus on automating in-mold labeling processes in the medium-performance area, Engel will continue to collaborate with its long-standing partner, IML Automation, for the high-performance segment.
March 2023: The MultiDose powder dosing device was developed by UK-based Labman Automation and collaborative robotics (cobots) firm Universal robotics in March 2023. Because of the MultiDose method, pharmaceutical companies may rapidly release drugs for testing and bring them to market. This automated, extremely precise tool for dispensing solids will cut the time spent on each experiment by technicians from six hours to just a few minutes.
August 2023: Knightscope, Inc., a market leader in autonomous security robots and blue light emergency communication systems, has signed a 7-robot contract with a publicly traded biotechnology firm that creates and sells treatments for deadly diseases. The contract is set to begin in August 2023. One K5 Autonomous Security Robot ("ASR") will be deployed to monitor a four-story parking garage for the new customer, and a total of six K1-Tower ASRs will keep watch over the company's main entrances, open spaces, and parking lots. Knightscope's tools will ensure the safety of everyone working in this state-of-the-art facility dedicated to improving people's health, as well as the materials and ideas they're developing.
Segmental Analysis
For the scope of report, MRFR offers a comprehensive segmental analysis of the global pharmaceutical robots market
By Type
-Articulated Robot
-SCARA Robots
-Delta/Parallel Robots
-Cartesian Robots
-Dual-arm Robots
-Others
By Application
By End-User
By Region
Intended Audience
Report Attribute/Metric | Details |
Market Size | USD 351 billion |
CAGR | 9.8% |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Type, By Application,By End-User |
Geographies Covered | Americas, Europe, Asia-Pacific, Middle East & Africa |
Key Vendors | Kawasaki Heavy Industries Ltd. (Japan),FANUC Corporation (Japan),KUKA AG (Germany),Universal Robots A/S (Denmark),Mitsubishi Electric Corporation (Japan),ABB Ltd. (Switzerland),Denso Corporation (Japan),Seiko Epson Corporation (Japan),Yaskawa Electric Corporation (Japan),Marchesini Group S.p.A (Italy),Shibuya Corporation (Japan). |
Key Market Opportunities | pharmaceutical robots that are covered in the report are traditional and collaborative robots |
Key Market Drivers | rising demand for high speed and precision. increasing the production of automated equipment |
The Pharmaceutical Robots Market can expand at 9.8% CAGR by 2030.
Kawasaki Heavy Industries Ltd. (Japan),FANUC Corporation (Japan),KUKA AG (Germany),Universal Robots A/S (Denmark),Mitsubishi Electric Corporation (Japan),ABB Ltd. (Switzerland),Denso Corporation (Japan),Seiko Epson Corporation (Japan),Yaskawa Electric Corporation are the key players of market
increasing the production of automated equipment are driving growth of the pharmaceutical robots market.
the Pharmaceutical Robots Market value USD 351 billion by 2030.
The North America region is the best-performing region of the global Pharmaceutical Robots Market
Key Questions Answered
Why Choose Market Research Future?